解读TERT/端粒酶对免疫和T细胞复苏的影响
Lingyi Huang1, Mingfu Zhang2, Ding Bai1
1Department of Orthodontics, West China College of Stomatology/State Key Laboratory of Oral Diseases, Sichuan University, Chengdu, China.
Frontiers in immunology
|October 8, 2024
概括
免疫衰老,即免疫系统的衰老,会损害T细胞功能,增加疾病风险. 增强端粒酶逆转录酶 (TERT) /端粒酶活性可能会对抗免疫细胞衰老.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
- 老年学是一门学科.
背景情况:
- 免疫性产生会影响先天性和适应性免疫,导致免疫缺陷.
- T细胞衰老是适应性免疫力下降的关键因素,增加感染,瘤和与年龄有关的疾病的风险.
- 淋巴细胞,特别是T细胞,经历复制性和过早衰老.
研究的目的:
- 审查了解免疫衰变的近期进展.
- 专注于T细胞衰老及其涉及端粒酶逆转录酶 (TERT) /端粒酶的调节机制.
- 讨论通过增强TERT/端粒酶活性来抑制免疫发生的策略.
主要方法:
- 文献综述最近关于免疫衰变的研究.
- 分析TERT/端粒酶在调节淋巴细胞衰老中的作用.
- 综合目前应对T细胞衰老的策略.
主要成果:
- 免疫性显著损害了适应性免疫力,特别是T细胞功能.
- TERT/端粒酶在调节淋巴细胞的复制性和过早衰老方面发挥着至关重要的作用.
- 增加TERT/端粒酶活性是一个有前途的策略来抑制免疫衰变.
结论:
- T细胞衰老是免疫衰老的关键组成部分,具有广泛的健康影响.
- TERT/端粒酶是T细胞衰老的关键调节剂,也是潜在的治疗点.
- 提高TERT/端粒酶活性的策略为打击与年龄相关的免疫衰退提供了一个有希望的途径.
相关概念视频
Telomeres and Telomerase
23.2K
In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded...
23.2K
Replicative Cell Senescence
3.6K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.6K
T Cell Activation and Clonal Selection
680
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
680
Tumor Immunotherapy
489
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
489
Cell-mediated Immune Responses
67.7K
Overview
67.7K
Multipotency of Hematopoietic Stem Cells
3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K


